Abstract Highly dense catalogs of human genetic variations, in combination with high-throughput genotyping technologies, are expected to clarify individual genetic differences in pharmacological responsiveness and predispositions to common diseases. Here we report single-nucleotide polymorphisms (SNPs) present among 48 Japanese individuals at the locus for the human ATP-binding cassette transporter A1 (ABCA1) gene. ABCA1 plays a key role in apolipoprotein-mediated cholesterol transport, and mutations in this gene are responsible for Tangier disease and familial high-density lipoprotein deficiency associated with reduced cholesterol efflux. We identified a total of 162 SNPs, 149 of which were novel, within the 150-kb region encompassing the entire ABCA1 gene. Eight of the SNPs lie within coding elements, two in 5Ј flanking regions, 147 in introns, and five in 3Ј untranslated regions, but none were found in 5Ј untranslated or 3Ј flanking regions. The ratio of transitions to transversions was approximately 2.37 to 1. Our dense SNP map of this region could serve as a powerful resource for studies of complex genetic diseases that may be associated with ABCA1 and of individual responses to drug therapy.
Introduction
The human ATP-binding cassette transporter A1 (ABCA1) gene encodes a 247-kDa membrane protein with two separate transmembrane portions, each consisting of six membrane-spanning domains and a nucleotide-binding fold. The regulatory domain contains a highly hydrophobic segment and is expressed on the plasma membrane and the Golgi complex (Luciani et al. 1994; Orso et al. 2000) . Functional analyses of ABCA1 have revealed roles in (1) regulation of the apolipoprotein A1-dependent cellular export of cholesterol and phopholipids Oram 2000) ; (2) engulfment of apoptotic cells by macrophages (Luciani and Chimini 1996; Hamon et al. 2000) ; (3) secretion of macrophage interleukin-1 beta (Hamon et al. 1997) ; and (4) caveolar processing (Orso et al. 2000) . The genomic sequence at the ABCA1 locus that has been determined so far includes 1453 bp of the promoter region, 146,581 bp of introns and exons, and 1000 bp of DNA downstream of the polyadenylation signal (Santamarina-Fojo et al. 2000) . The gene itself consists of 50 exons ranging from 33 to 245 bp. Relationships between ABCA1 gene and human dyslipidemic diseases have been investigated intensively; mutations of ABCA1 gene can be found in patients with Tangier disease and in persons with familial high-density lipoprotein (HDL) deficiency associated with reduced cholesterol efflux (Bodzioch et al. 1999; Brooks-Wilson et al. 1999; Marcil et al. 1999; Rust et al. 1999) . Recently Clee et al. (2001) isolated 16 single-nucleotide polymorphisms (SNPs) from coding elements of the ABCA1 gene and revealed that some are associated with altered plasma lipid levels and risk of coronary artery disease.
Variations in genes that encode drug-transporter and drug-metabolizing enzymes may be associated with susceptibility to common diseases and with differences in therapeutic efficacy and side effects of drugs among individual persons, because some variations can alter the activity of a gene product with respect to quality, quantity, or both. Therefore, information concerning naturally occurring genetic variants in human transporter genes such as ABCA1 Table 2 ). Microsatellite sequences are also shown is an important resource for understanding not only the etiology and risk of some diseases, but also the pharmacokinetics or pharmacodyamics of drugs used to treat them. We have focused on identifying variations in genomic regions that contain drug-metabolizing enzymes, and so far have isolated 1066 SNPs among 71 such loci (lida et al. 2001a,b; Saito et al. 2001; Saito et al., in preparation; Sekine et al. 2001) . We report here a total of 162 SNPs spanning the entire ABCA1 genomic region, detected among 96 chromosomes in a Japanese population sample.
Subjects and methods
DNA samples, PCR, direct sequencing, and detection of SNPs Blood samples were obtained with informed consent from 48 healthy Japanese individuals for this study, which was approved by the ethical committee of the RIKEN SNP Research Center. On the basis of ABCA1-genomic sequences (accession numbers AF275948.1 and AL359846.11), released from the GenBank database, and information published by Remaley et al. (1999) and Santamarina-Fojo et al. (2000) , we designed primers to amplify the ABCA1 gene in its entirety as well as up to 2 kb upstream from the first exon and downstream of the last exon. We eliminated most of the regions corresponding to repetitive sequences predicted by the RepeatMasker program (http://ftp. genome.washington.edu/cgibin/ RepeatMasker). Genomic DNA extraction, polymerase chain reaction (PCR) experiments, and DNA sequencing were performed according to methods described previously (Ohnishi et al. 2000) . Each PCR was performed using 20 ng of DNA pooled from three individuals. All SNPs detected by the PolyPhred computer program (Nickerson et al. 1997) were confirmed by sequencing both strands of each PCR product.
Results and discussion
We present here a highly dense SNP map covering the 150-kb genomic region that contains the entire human ABCA1 gene. A total of 91 partially overlapping PCR fragments, covering 57.4% of the 150-kb ABCA1 gene locus, were sequenced using 364 primers. The organization of the ABCA1 gene and locations of identified SNPs are illustrated schematically in Fig. 1 . A total of 162 SNPs were identified: eight were located in coding elements, two in the 5Ј flanking region, 147 in introns, and five in the 3Ј untranslated region (Table 1 ; also see Fig. 1 ). No SNP was detected in the 5Ј untranslated or 3Ј flanking regions. Comparison of our data with SNPs deposited in the dbSNP database in the National Center for Biotechnology Information (NCBI, U.S.) and an earlier report (Clee et al. 2001 ) indicated that 149 (94%) of the SNPs identified in this study could be considered novel. As a whole, 154 of the 162 SNPs identified (95.0%) were located within 79.4 kb of DNA representing noncoding exons, introns, and resequenced flanking regions (1SNP/ 516 bp), whereas only 8 SNPs were present in 6783 bp of the coding DNA screened (1SNP/848 bp). Therefore, the frequency of SNPs in noncoding portions of the ABCA1 gene was 1.64-fold higher than in coding elements. Frequencies of the substitutions were 35.8% for A/G, 34.6% for C/T, 11.7% for C/G, 6.8% for G/T, 6.2% for A/T, and 4.9% for A/C. The ratio of transitions to transversions was approximately 2.37 to 1. The higher prevalence of A/G substitutions and the transition/transversion ratio are both in close accord with previous observations (Cambien et al. 1999; Iida et al. 2001a,b; Venter et al. 2001) . In addition to SNPs, we identified eight novel insertion/deletion polymorphisms within introns of the ABCA1 gene (Table 2) .
Among 13 SNPs identified in exonic regions, the 4 nonsynonymous sites that we found in coding elements had been reported previously (Clee et al. 2001) . Although the frequency of the coding SNPs, particularly nonsynonymous ones, was very small, they would be likely to influence protein function. In fact, it is reported that the R219K substitution is associated with a decreased severity of atherosclerosis, a decreased risk of coronary events, decreased triglycerides, and a higher level of HDL cholesterol (HDL-C) in plasma (Clee et al. 2001) . Moreover, since the regulatory elements for gene expression are contained in 5Ј promoter regions and introns and occasionally in 3Ј flanking regions, SNPs within those regions may affect the quantity of the gene product. In light of recent progress in understanding the biomedical features of ABCA1, the SNPs documented here will be useful not only for studying associations between specific SNPs and some coronary diseases, but also for determining the applicability of pharmacogenomic information to medical practice.
